98%
921
2 minutes
20
Objective: To qualitatively analyze the supportive care needs (including health education and nursing care) of anal fistula patients after fistulotomy using the Kano model.
Methods: A total of 183 anal fistula patients who underwent fistulotomy from December 2021 to December 2023 were selected via cluster sampling. Sociodemographic data were collected, and a self-designed questionnaire based on the Kano model (validated through two rounds of expert consultation and referring to the related literature) was used to assess patients' supportive care needs. The questionnaire covered health education needs (eg, delivery methods, content) and nursing needs (eg, physiological and psychological support). Satisfaction indices (SI), dissatisfaction indices (DSI), and a DSI-SI matrix were calculated.
Results: Among 12 health education needs, 3 were Must-be (M) (25.00%), 4 were One-dimensional (O) (33.33%), 4 were Attractive (A) (33.33%), and 1 was Indifferent (I) (8.33%). The DSI-SI matrix identified 2 high-priority (16.67%), 2 to-be-improved (16.67%), 3 secondary-improvement (25.00%), and 5 low-priority (41.67%) items. Among 12 nursing needs, 2 were M (16.67%), 3 were O (25.00%), and 7 were A (58.33%). The matrix showed 1 high-priority (8.33%), 1 to-be-improved (8.33%), 1 secondary-improvement (8.33%), and 9 low-priority (41.67%) items.
Conclusion: The Kano model effectively identifies supportive care needs for anal fistula patients post-surgery, providing a comprehensive basis for precision treatment and postoperative nursing.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12399089 | PMC |
http://dx.doi.org/10.2147/JMDH.S535960 | DOI Listing |
Nutr Clin Pract
September 2025
Department of Pediatrics, Mayo Clinic, Rochester, Minnesota, USA.
Home parenteral nutrition (HPN) is a life-sustaining therapy traditionally used as a bridge to enteral autonomy or intestinal transplantation. Increasingly, it is used for intractable feeding intolerance (IFI), which can occur near the end of life (EOL) in children with severe neurological impairment (SNI). In these cases, HPN use differs from its historical role and requires tailored outpatient planning.
View Article and Find Full Text PDFPharmacoecon Open
September 2025
Acaster Lloyd Consulting Ltd, Lacon House, 84 Theobalds Rd, London, WC1X 8NL, UK.
Background: Isocitrate dehydrogenase-mutant (mIDH) gliomas are malignant central nervous system tumours. After initial resection, patients with mIDH gliomas with favourable prognosis may live without receiving oncologic treatment for years, but ultimately patients will experience recurrence and require radio- and/or chemotherapy (RT/CT). Cost-utility analyses (CUA) can explore the value of treatments that delay recurrence and initiation of RT/CT.
View Article and Find Full Text PDFBr J Anaesth
September 2025
Tissue Repair and Regeneration Laboratory (TR2Lab), Institut de Recerca i Innovació en Ciències de la Vida i la Salut a la Catalunya Central (IrisCC), Vic, Barcelona, Spain; Department of Internal Medicine, Hospital d'Olot i comarcal de la Garrotxa, Olot, Girona, Spain; Faculty of Medicine, Univer
Bull Cancer
September 2025
Department of Pathology and Medical Biology, Cancer Genetics Laboratory, Gustave Roussy, Villejuif, France.
The effectiveness and tolerability of medicines can vary considerably from person to person, even at the same dose. This variation is influenced by many factors, including constitutional genetic characteristics. In fact, some people have genetic variations that are common and neutral in the population, known as polymorphisms, which can affect drug metabolism or make them more susceptible to certain adverse effects.
View Article and Find Full Text PDFNeurologia (Engl Ed)
September 2025
Servicio de Neurología, CHUAC, Complejo Universitario de A Coruña, A Coruña, Spain.
Introduction: One of the current challenges in Parkinson's disease (PD) and other movement disorders (MD) is how and when to apply palliative care. Aware of the scarce training and implementation of this type of approach, we propose some consensual recommendations for palliative care (PC) in order to improve the quality of life of patients and their environment.
Material And Methods: After a first phase of needs analysis through a survey carried out on Spanish neurologists and a review of the literature, we describe recommendations for action structured in: palliative care models, selection of the target population, when, where and how to implement the PC.